• Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
Quantisnow Logo
  • Live Feeds
    • Press Releases
    • Insider Trading
    • FDA Approvals
    • Analyst Ratings
    • Insider Trading
    • SEC filings
    • Market insights
  • Analyst Ratings
  • Alerts
  • Subscriptions
  • Settings
  • RSS Feeds
PublishDashboard
    Quantisnow Logo

    © 2025 quantisnow.com
    Democratizing insights since 2022

    Services
    Live news feedsRSS FeedsAlertsPublish with Us
    Company
    AboutQuantisnow PlusContactJobsAI employees
    Legal
    Terms of usePrivacy policyCookie policy

    SEC Form 424B3 filed by JP Morgan Chase & Co.

    6/4/25 1:05:34 PM ET
    $JPM
    Major Banks
    Finance
    Get the next $JPM alert in real time by email
    424B3 1 ea0244694-01_424b3.htm FORM 424B3

    Index supplement to the prospectus dated April 13, 2023, the prospectus supplement dated April 13, 2023, the prospectus addendum dated June 3, 2024, the product supplement no. 4 - I dated April 13, 2023 and the underlying supplement no. 8 - I dated April 13, 2023. Registration Statement Nos. 333 - 270004 and 333 - 270004 - 01 Dated June 3, 2025 Rule 424(b)(3) PERFORMANCE UPDATE The J.P. Morgan Kronos SM US Equity (JPUSKRSP) Index attempts to provide a dynamic 50%, 100% or 150% exposure to the S&P 500® Price Index (“the S&P 500”) based on the following principles: • Strong historical performance around the turn of the month • Historical price momentum ahead of index options’ expiry • Historical mean reversion at month - end The Index does not reflect the reinvestment of dividends and is subject to a daily deduction of 0.35% per annum index fee The Index was established on June 11, 2021. Levels are published on Bloomberg using the ticker JPUSKRSP. Hypothetical and actual historical performance: May 2015 through May 2025 J.P. Morgan Kronos US Equity (JPUSKRSP) Index S&P 500® Total Return Index 50 Backtested Actual May - 15 May - 17 May - 19 May - 21 May - 23 May - 25 Please see the footnotes at the bottom of this page and “Backtesting” on the following page for information on backtested performance. 250 450 650 Hypothetical and actual historical returns and volatilities: May 2015 through May 2025 Sharpe Ratio 10 Year Volatility (Annualized) 10 Year Return (Annualized) 5 Year Return (Annualized) 3 Year Return (Annualized) 1 Year Return 0.70 21.72% 15.14% 13.71% 7.63% 0.50% J.P. Morgan Kronos US Equity (JPUSKRSP) Index 0.70 18.48% 12.86% 15.94% 14.41% 13.52% S&P 500® Total Return Index Historical exposure at end - of - day: Mar 2025 through May 2025 Hypothetical and actual historical monthly and annual returns: Jan 2016 through May 2025 Year Dec Nov Oct Sep Aug Jul Jun May Apr Mar Feb Jan 10.68% 2.24% 2.70% - 2.76% - 0.30% - 0.12% 3.82% 0.80% 2.19% - 0.46% 9.17% - 2.00% - 4.42% 2016 23.59% 1.02% 2.60% 2.62% 1.77% 1.46% 2.06% 0.95% 1.44% 0.68% 0.68% 4.26% 1.88% 2017 3.42% - 7.20% 5.21% - 6.85% 0.54% 2.89% 4.06% 2.36% 3.48% 1.40% - 1.57% - 7.23% 7.71% 2018 32.25% 2.63% 3.99% 0.88% 2.57% - 3.45% 1.49% 9.82% - 8.68% 4.15% 3.15% 3.92% 9.16% 2019 53.87% 4.21% 13.25% - 1.35% - 2.56% 7.51% 6.75% 4.66% 3.68% 12.59% 0.69% - 5.12% 1.25% 2020 34.66% 4.31% 0.85% 9.18% - 4.86% 3.28% 1.23% 1.71% 1.69% 6.25% 2.54% 3.77% 0.80% 2021 - 28.46% - 10.62% 3.18% 8.99% - 10.90% - 4.84% 10.54% - 8.61% 4.55% - 12.37% - 1.19% - 1.55% - 6.76% 2022 28.43% 4.29% 11.42% - 1.13% - 6.20% - 1.86% 2.41% 7.99% - 2.22% 2.04% 6.06% - 2.62% 6.56% 2023 17.12% - 3.71% 5.90% - 1.12% 0.03% - 2.19% 1.93% 3.83% 7.22% - 4.65% 3.06% 5.47% 0.94% 2024 - 3.74% 6.74% - 1.37% - 9.31% - 1.01% 1.85% 2025 JUNE 2025 J.P. Morgan Kronos US Equity (JPUSKRSP) Index Historical performance measures for the Index represent hypothetical backtested performance using the actual performance of the S&P 500® Price Return Index through June 10, 2021 and the actual performance of the Index from June 11, 2021 through May 31, 2025. PAST PERFORMANCE AND BACKTESTED PERFORMANCE ARE NOT INDICATIVE OF FUTURE RESULTS. Please see the Disclaimer on the following page. Investing in the notes linked to the Index involves a number of risks. See “Selected Risks” on page 2 of this document, “Risk Factors” in the relevant product supplement and underlying supplement and “Selected Risk Considerations” in the relevant pricing supplement. Neither the Securities and Exchange Commission nor any state securities commission has approved or disapproved of the notes or passed upon the accuracy or the adequacy of this document or the accompanying product supplement, underlying supplement, prospectus supplement or prospectus. Any representation to the contrary is a criminal otfense. The notes are not bank deposits, are not insured by the Federal Deposit Insurance Corporation or any other governmental agency and are not obligations of, or guaranteed by, a bank. May 2025 150% 100% 50% S&P 500® Exposure 5/1 — 5/5 5/6 — 5/12 5/13 — 5/16 5/19 — 5/20 5/21 — 5/27 5/28 — 5/29 5/30 Mar 2025 150% 100% 50% S&P 500® Exposure 3/3 — 3/5 3/6 — 3/17 3/18 — 3/20 3/21 3/24 — 3/26 3/27 — 3/28 3/31 Apr 2025 150% 100% 50% S&P 500® Exposure 4/1 — 4/3 4/4 — 4/11 4/14 — 4/17 4/21 4/22 — 4/25 4/28 — 4/29 4/30

     
     

    JUNE 2025 | J.P. Morgan Kronos US Equity (JPUSKRSP) Index Selected Risks  Our affiliate, J.P. Morgan Securities LLC (“JPMS”), is the sponsor and calculation agent of the Index and may adjust the Index in a way that atfects its level.  The level of the Index will include the deduction of a fee of 0.35% per annum and, in some circumstances, a notional financing cost based on the Etfective Federal Funds Rate.  JPMorgan Chase & Co. is currently one of the companies that make up the Constituent.  There are risks associated with the Index’s turn - of - month strategy.  There are risks associated with the Index’s option expiry momentum strategy.  There are risks associated with the Index’s mean reversion strategy.  The Index’s strategies are applied during only a portion of each month.  The Index may be adversely atfected by an overlap between its turn - of - the - month strategy and its month - end mean reversion strategy.  The Index may be uninvested in the Constituent.  The Constituent of the Index may be replaced by a substitute index in certain extraordinary events.  The notional cash return will be negatively atfected if the underlying interest rate is negative.  The Index, which was established on June 11, 2021, has a limited operating history and may perform in unanticipated ways.  The Index comprises notional assets and liabilities. There is no actual portfolio of assets to which any person is entitled or in which any person has any ownership interest.  The Index may not be successful or outperform any alternative strategy that may be employed of the Constituents.  The Etfective Federal Funds Rate is atfected by a number of factors and may be volatile.  The method pursuant to which the Etfective Federal Funds Rate is determined may change, and any such change may adversely atfect the value of notes linked to the Index. The risks identified above are not exhaustive. You should also review carefully the related “Risk Factors” section in the prospectus supplement and the relevant product supplement and underlying supplement and the “Selected Risk Considerations” in the relevant pricing supplement. Disclaimer The information contained in this document is for discussion purposes only . Any information relating to performance contained in these materials is illustrative and no assurance is given that any indicative returns, performance or results, whether historical or hypothetical, will be achieved . These terms are subject to change, and J . P . Morgan undertakes no duty to update this information . This document shall be amended, superseded and replaced in its entirety by a subsequent term sheet and/or disclosure supplement, and the documents referred to therein . In the event any inconsistency between the information presented herein and any such term sheet and/or disclosure supplement, such term sheet and/or disclosure supplement shall govern . Backtesting : Hypothetical backtested performance measures have inherent limitations . Alternative modelling techniques might produce significantly ditferent results and may prove to be more appropriate . Past performance, and especially hypothetical back - tested performance, is not indicative of future results . This type of information has inherent limitations and you should carefully consider these limitations before placing reliance on such information . The 10 Year Volatility (Annualized) on the previous page is a measure of market risk, calculated as of the square root of two hundred and fifty - two ( 252 ) multiplied by the sample standard deviation of the daily logarithmic returns of each applicable index or portfolio (considering only days for which levels are available for all three) over the preceding 10 years . The Sharpe Ratio on the previous page is a measure of risk - adjusted performance, calculated as the 10 Year Return (Annualized) divided by the 10 Year Volatility (Annualized) . Investment suitability must be determined individually for each investor, and notes linked to the Index may not be suitable for all investors . This material is not a product of J . P . Morgan Research Departments . Copyright © 2025 JPMorgan Chase & Co . All rights reserved . For additional regulatory disclosures, please consult : www . jpmorgan . com/disclosures . Information contained on this website is not incorporated by reference in, and should not be considered part of, this document . This monthly update document replaces and supersedes all prior written materials of this type previously provided with respect to the Index .

     
    Get the next $JPM alert in real time by email

    Chat with this insight

    Save time and jump to the most important pieces.

    Recent Analyst Ratings for
    $JPM

    DatePrice TargetRatingAnalyst
    5/15/2025$305.00Buy
    TD Cowen
    3/7/2025$215.00 → $220.00Underperform → Neutral
    Robert W. Baird
    1/3/2025$269.00Peer Perform → Outperform
    Wolfe Research
    11/20/2024Outperform → Perform
    Oppenheimer
    11/7/2024$200.00Neutral → Underperform
    Robert W. Baird
    9/30/2024$220.00 → $224.00Overweight → Equal-Weight
    Morgan Stanley
    9/3/2024$235.00Buy → Hold
    Deutsche Bank
    8/20/2024$240.00Buy → Outperform
    Daiwa Securities
    More analyst ratings

    $JPM
    Financials

    Live finance-specific insights

    See more
    • JPMorganChase Declares Common Stock Dividend

      JPMorgan Chase & Co. (NYSE:JPM) ("JPMorganChase" or the "Firm") declared a quarterly dividend on the outstanding shares of the common stock of JPMorganChase. Information can be found on the Firm's Investor Relations website at https://www.jpmorganchase.com/ir/news. JPMorgan Chase & Co. (NYSE:JPM) is a leading financial services firm based in the United States of America ("U.S."), with operations worldwide. JPMorganChase had $4.4 trillion in assets and $351 billion in stockholders' equity as of March 31, 2025. The Firm is a leader in investment banking, financial services for consumers and small businesses, commercial banking, financial transaction processing and asset management. Under the

      5/19/25 4:35:00 PM ET
      $JPM
      Major Banks
      Finance
    • JPMorganChase Declares Preferred Stock Dividends

      JPMorgan Chase & Co. (NYSE:JPM) ("JPMorganChase" or the "Firm") has declared dividends on the outstanding shares of the Firm's Series II and OO preferred stock. Information can be found on the Firm's Investor Relations website at https://www.jpmorganchase.com/ir/news. JPMorgan Chase & Co. (NYSE:JPM) is a leading financial services firm based in the United States of America ("U.S."), with operations worldwide. JPMorganChase had $4.4 trillion in assets and $351 billion in stockholders' equity as of March 31, 2025. The Firm is a leader in investment banking, financial services for consumers and small businesses, commercial banking, financial transaction processing and asset management. Under

      5/15/25 4:25:00 PM ET
      $JPM
      Major Banks
      Finance
    • JPMorganChase Declares Preferred Stock Dividends

      JPMorgan Chase & Co. (NYSE:JPM) ("JPMorganChase" or the "Firm") has declared dividends on the outstanding shares of the Firm's Series DD, EE, GG, JJ, KK, LL, MM and NN preferred stock. Information can be found on the Firm's Investor Relations website at https://www.jpmorganchase.com/ir/news. JPMorgan Chase & Co. (NYSE:JPM) is a leading financial services firm based in the United States of America ("U.S."), with operations worldwide. JPMorganChase had $4.4 trillion in assets and $351 billion in stockholders' equity as of March 31, 2025. The Firm is a leader in investment banking, financial services for consumers and small businesses, commercial banking, financial transaction processing and

      4/15/25 4:33:00 PM ET
      $JPM
      Major Banks
      Finance

    $JPM
    Large Ownership Changes

    This live feed shows all institutional transactions in real time.

    See more
    • SEC Form SC 13D filed by JP Morgan Chase & Co.

      SC 13D - JPMORGAN CHASE & CO (0000019617) (Filed by)

      9/12/24 2:46:34 PM ET
      $JPM
      Major Banks
      Finance
    • Amendment: SEC Form SC 13G/A filed by JP Morgan Chase & Co.

      SC 13G/A - JPMORGAN CHASE & CO (0000019617) (Filed by)

      8/9/24 1:40:34 PM ET
      $JPM
      Major Banks
      Finance
    • SEC Form SC 13G/A filed by JP Morgan Chase & Co. (Amendment)

      SC 13G/A - JPMORGAN CHASE & CO (0000019617) (Subject)

      2/13/24 4:55:49 PM ET
      $JPM
      Major Banks
      Finance

    $JPM
    Leadership Updates

    Live Leadership Updates

    See more
    • J.P. Morgan Life Sciences Private Capital Welcomes Dashyant Dhanak, Ph.D. as Venture Partner

      NEW YORK, May 19, 2025 /PRNewswire/ -- J.P. Morgan Life Sciences Private Capital, the life sciences venture and growth equity arm within J.P. Morgan Asset Management, today announced the appointment of Dashyant (Dash) Dhanak, Ph.D., as Venture Partner. Dr. Dhanak will leverage his deep scientific and operational experience in therapeutics research and development to build and grow companies with Life Sciences Private Capital. Dr. Dhanak is a seasoned pharmaceutical research and development expert with over 30 years of experience. Most recently, Dr. Dhanak was the Chief Scienti

      5/19/25 10:00:00 AM ET
      $JPM
      Major Banks
      Finance
    • J.P. Morgan Asset Management Focuses on Generational Opportunities in Real Estate, Appointing Chad Tredway as Global Head

      New role unifies asset manager's global real estate offering and expands access to firmwide capabilities NEW YORK, May 14, 2025 /PRNewswire/ -- J.P. Morgan Asset Management is enhancing its real estate business with the appointment of Chad Tredway as Global Head of Real Estate. In this new role, he will oversee real estate operations across the Americas, Europe, and Asia Pacific, increasing the firm's global reach and ability to deliver innovative investment opportunities. Mr. Tredway has a proven track record of managing real estate assets for retail and institutional client

      5/14/25 12:00:00 PM ET
      $JPM
      Major Banks
      Finance
    • Campbell Global Announces Leadership Transition: Angie Davis to Succeed John Gilleland as CEO

      PORTLAND, Ore., May 12, 2025 /PRNewswire/ -- Campbell Global, a leader in forestland investing and management, and a vital part of J.P. Morgan Asset Management's $400 billion alternatives business, is pleased to announce a significant leadership transition. Angie Davis, currently serving as President of Campbell Global, will succeed John Gilleland as Chief Executive Officer, effective October 1. Campbell Global, a pioneer in timberland investing, has been a full-service investment advisor focusing solely on commercial forestlands and related assets. Operating in core forest in

      5/12/25 3:00:00 PM ET
      $JPM
      Major Banks
      Finance

    $JPM
    Press Releases

    Fastest customizable press release news feed in the world

    See more
    • JPMorganChase Accelerates Affluent Offering by Opening 14 New Financial Centers in Four States

      Plans call for 31 New Financial Centers to be opened by end of 2026 JPMorganChase today announced it is expanding its affluent banking offering by opening 14 new J.P. Morgan Financial Centers across four states, bringing a uniquely tailored and high-touch experience to millions of potential clients. JPMorganChase leaders will officially open the new centers this week in California, Florida, Massachusetts and New York in local ribbon-cutting ceremonies. Combined with the two J.P. Morgan Financial Centers that opened in late 2024, the firm has a total of 16 locations, with plans to nearly double that by the end of next year. "Through these Financial Centers, we are redefining how afflue

      5/27/25 11:16:00 AM ET
      $JPM
      Major Banks
      Finance
    • JPMorgan Chase Financial Company LLC Declares Quarterly Coupon on Alerian MLP Index ETN

      JPMorgan Chase Financial Company LLC announced today the quarterly coupon amount for the Alerian MLP Index ETN (NYSE:AMJB). The table below summarizes the coupon amount for the Alerian MLP Index ETN due January 28, 2044 (the "Notes"). NYSE Arca Ticker Registered Issue Name Declaration Date Ex-Date Record Date Payment Date Coupon Amount1 per Note Current Yield2 AMJB Alerian MLP Index ETN May 22, 2025 May 29, 2025 May 29, 2025 June 6, 2025 $0.4836 6.3% 1) As defined in the pricing supplement, dated May 14, 2024 for the Notes. You may access this pricing supplement as follows: https://www.sec.gov/Archives/edgar/data/19617/0001213900240430

      5/22/25 4:15:00 PM ET
      $JPM
      Major Banks
      Finance
    • JPMorganChase Announces Conference Calls to Review First-Quarter, Second-Quarter, Third-Quarter and Fourth-Quarter 2026 Earnings

      JPMorgan Chase & Co. (NYSE:JPM) ("JPMorganChase" or the "Firm") plans to host conference calls to review financial results on the following dates: First-quarter 2026 – Tuesday, April 14, 2026 at 8:30 a.m. (Eastern) Second-quarter 2026 – Tuesday, July 14, 2026 at 8:30 a.m. (Eastern) Third-quarter 2026 – Tuesday, October 13, 2026 at 8:30 a.m. (Eastern) Fourth-quarter 2026 – Thursday, January 14, 2027 at 8:30 a.m. (Eastern) The financial results are scheduled to be released at approximately 6:45 a.m. (Eastern) on the dates noted above, and live audio webcasts and presentation slides will be made available on www.jpmorganchase.com under Investor Relations, Events & Presentations. Dial

      5/21/25 4:47:00 PM ET
      $JPM
      Major Banks
      Finance

    $JPM
    Insider Trading

    Insider transactions reveal critical sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Chief Operating Officer Piepszak Jennifer sold $1,608,424 worth of shares (6,128 units at $262.47), decreasing direct ownership by 9% to 62,455 units (SEC Form 4)

      4 - JPMORGAN CHASE & CO (0000019617) (Issuer)

      6/5/25 6:04:18 PM ET
      $JPM
      Major Banks
      Finance
    • General Counsel Friedman Stacey sold $2,505,410 worth of shares (9,429 units at $265.71), decreasing direct ownership by 15% to 36,520 units (SEC Form 4)

      4 - JPMORGAN CHASE & CO (0000019617) (Issuer)

      5/20/25 5:19:32 PM ET
      $JPM
      Major Banks
      Finance
    • CEO CCB Lake Marianne sold $3,278,087 worth of shares (12,274 units at $267.08), decreasing direct ownership by 16% to 63,404 units (SEC Form 4)

      4 - JPMORGAN CHASE & CO (0000019617) (Issuer)

      5/16/25 5:12:56 PM ET
      $JPM
      Major Banks
      Finance

    $JPM
    SEC Filings

    See more
    • SEC Form 424B3 filed by JP Morgan Chase & Co.

      424B3 - JPMORGAN CHASE & CO (0000019617) (Filer)

      6/5/25 3:57:58 PM ET
      $JPM
      Major Banks
      Finance
    • SEC Form FWP filed by JP Morgan Chase & Co.

      FWP - JPMORGAN CHASE & CO (0000019617) (Subject)

      6/5/25 1:08:48 PM ET
      $JPM
      Major Banks
      Finance
    • SEC Form FWP filed by JP Morgan Chase & Co.

      FWP - JPMORGAN CHASE & CO (0000019617) (Subject)

      6/4/25 8:18:53 PM ET
      $JPM
      Major Banks
      Finance

    $JPM
    Insider Purchases

    Insider purchases reveal critical bullish sentiment about the company from key stakeholders. See them live in this feed.

    See more
    • Large owner Jpmorgan Chase & Co sold 14 shares and bought $51 worth of shares (14 units at $3.67) (SEC Form 4)

      4 - JPMORGAN CHASE & CO (0000019617) (Reporting)

      4/11/25 4:55:53 PM ET
      $JPM
      Major Banks
      Finance

    $JPM
    Analyst Ratings

    Analyst ratings in real time. Analyst ratings have a very high impact on the underlying stock. See them live in this feed.

    See more
    • TD Cowen initiated coverage on JPMorgan Chase with a new price target

      TD Cowen initiated coverage of JPMorgan Chase with a rating of Buy and set a new price target of $305.00

      5/15/25 8:12:03 AM ET
      $JPM
      Major Banks
      Finance
    • JPMorgan Chase upgraded by Robert W. Baird with a new price target

      Robert W. Baird upgraded JPMorgan Chase from Underperform to Neutral and set a new price target of $220.00 from $215.00 previously

      3/7/25 7:45:01 AM ET
      $JPM
      Major Banks
      Finance
    • JPMorgan Chase upgraded by Wolfe Research with a new price target

      Wolfe Research upgraded JPMorgan Chase from Peer Perform to Outperform and set a new price target of $269.00

      1/3/25 7:36:18 AM ET
      $JPM
      Major Banks
      Finance